Document is current
Any future updates will be listed below
-
Authors
Islam, Farhana
Das, Srijanee https://orcid.org/0000-0002-2792-0718
Ashaduzzaman, Md
Sillman, Brady
Yeapuri, Pravin
Nayan, Mohammad Ullah
Oupický, David https://orcid.org/0000-0003-4710-861X
Gendelman, Howard E. https://orcid.org/0000-0002-7831-0370
Kevadiya, Bhavesh D.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH121402-05)
- License Information
-
More Information
Article History
Received: 13 November 2023
Accepted: 15 July 2024
First Online: 30 July 2024
Competing interests
: The authors declare that H.E.G. is a co-founder of Exavir Therapeutics, Inc. The biotechnology company is developing ultra-long-acting drugs. The drugs currently in development are not linked to any medicines developed in the current report. All other authors declare no competing interests.
